Literature DB >> 3924012

Effect of enzootic pneumonia of pigs on growth performance.

A M Pointon, D Byrt, P Heap.   

Abstract

Growing pigs were naturally infected with a field strain of Mycoplasma hyopneumoniae to assess the effect of enzootic pneumonia on production. Both the initial ("breakdown") and endemic stages of infection were evaluated. The pigs were reared under environmental and management conditions commonly found on commercial piggeries in South Australia. Growth rate of pigs held in-contact with inoculated pigs was reduced by 12.7% (p less than 0.01) between 50 to 85 kg bodyweight. In the second trial inoculated gilts were used to naturally infect piglets during suckling. Growth rate of infected pigs was reduced by 15.9% (p less than 0.001) between 8 to 85 kg bodyweight, while feed conversion was depressed by 13.8% (p less than 0.05) between 10 to 25 kg bodyweight. At current feed and production costs this reduced performance added approximately $2.80 to the cost of every pig produced. These losses were recorded in groups of pigs in which enzootic pneumonia was present. At slaughter, 40% of lungs contained gross lesions of enzootic pneumonia which were free of significant secondary bacteria. The nature of the infection was established by gross and microscopic pathology and confirmed by the detection of specific complement fixing antibody in infected pigs and the demonstration of M. hyopneumoniae by direct immunofluorescent staining of lung sections.

Entities:  

Mesh:

Year:  1985        PMID: 3924012     DOI: 10.1111/j.1751-0813.1985.tb06032.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  13 in total

1.  Dynamics and persistence of Mycoplasma hyopneumoniae infection in pigs.

Authors:  Eduardo Fano; Carlos Pijoan; Scott Dee
Journal:  Can J Vet Res       Date:  2005-07       Impact factor: 1.310

2.  Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF).

Authors:  P K Fagan; S P Djordjevic; J Chin; G J Eamens; M J Walker
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  A system response to an outbreak of enzootic pneumonia in grow/finish pigs.

Authors:  Leeanne E Bargen
Journal:  Can Vet J       Date:  2004-10       Impact factor: 1.008

4.  Infection of growing swine with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae--effects on growth, serum metabolites, and insulin-like growth factor-I.

Authors:  N Elizabeth Roberts; Glen W Almond
Journal:  Can Vet J       Date:  2003-01       Impact factor: 1.008

5.  Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia.

Authors:  P K Fagan; S P Djordjevic; G J Eamens; J Chin; M J Walker
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  An abattoir survey of pneumonia and pleuritis in slaughter weight swine from 9 selected herds. I. Prevalence and morphological description of gross lung lesions.

Authors:  B M Lium; K Falk
Journal:  Acta Vet Scand       Date:  1991       Impact factor: 1.695

7.  An epidemiologic and economic study of respiratory diseases in two conventional Danish swine herds. II: Associations between lesions present at slaughter and mean daily gains during specific intervals of the growth period.

Authors:  L G Paisley; L Vraa-Andersen; L Dybkjaer; K Møller; G Christensen; J Mousing; J F Agger
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

8.  An epidemiologic and economic study of respiratory diseases in two conventional Danish swine herds. I: Prevalence of respiratory lesions at slaughter and their effects on growth.

Authors:  L G Paisley; L Vraa-Andersen; L Dybkjaer; K Møller; G Christensen; J Mousing; J F Agger
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

9.  Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232.

Authors:  Ken Pendarvis; Matthew P Padula; Jessica L Tacchi; Andrew C Petersen; Steven P Djordjevic; Shane C Burgess; F Chris Minion
Journal:  BMC Genomics       Date:  2014-07-08       Impact factor: 3.969

10.  Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.

Authors:  Annelies Michiels; Ioannis Arsenakis; Filip Boyen; Roman Krejci; Freddy Haesebrouck; Dominiek Maes
Journal:  BMC Vet Res       Date:  2017-08-29       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.